Tag:
SpringLeaf Therapeutics
Latest Headlines
Latest Headlines
GSK venture group backs SpringLeaf in $15M round
SpingLeaf Therapeutics has closed a $15 million Series B round of venture capital to advance its first drug-device combination product toward the clinic, with GlaxoSmithKline's ($GSK) venture unit,
